Future Extraordinaire

Ep 4A: From rare diseases to COVID-19: Charting the future of healthcare with genomics

October 29, 2020
Future Extraordinaire
Ep 4A: From rare diseases to COVID-19: Charting the future of healthcare with genomics
Show Notes Chapter Markers

The Human Genome Project, initiated in 1990, was completed in 2003 at an estimated cost of US$2.7 billion with the collaborative efforts of institutions and laboratories in countries including the US, UK, Japan China, Germany and France. Genomic technology has made major impact in the fields of medicine, biotechnology, life sciences, diseases and viruses.

How can genomics help in our battle against COVID-19? Join us for an insightful conversation with Joep de Ligt, Lead Bioinformatics & Genomics from the Institute of Environmental Science and Research Limited. In part one, Joep shares about his role and how genome sequencing can help trace the sources of COVID-19 outbreaks. He also chats with us on his career journey and why he chose to move from the Netherlands to New Zealand.

In part two, we  examine the role of technologies like containerization in biological researches and analysis; how genome sequencing at sites of Ebola and Zika outbreaks provides health intelligence; and how is the future better with genome technology. 


03:40 – 04:37 Introduction to Lead Bioinformatics and Geonomics

04:38 – 05:51 Joep’s career journey

06:02 – 07:58 Migrating from Netherlands to New Zealand

08:15 – 10:16 How genome sequencing is solving diseases worldwide

10:25 – 14:13 How genome sequencing work

14:24 – 17:54 Progression of COVID-19 and the future of vaccines

17:58 – 20:18 How are governments investing in sequencing to solve health challenges

20:33 – 22:42 Progress of sequencing and how effective is it in managing viruses now

Introduction to Lead Bioinformatics and Geonomics
Joep’s career journey
Migrating from Netherlands to New Zealand
How genome sequencing is solving diseases worldwide
How genome sequencing work
Progression of COVID-19 and the future of vaccines
How are governments investing in sequencing to solve health challenges
Progress of sequencing and how effective is it in managing viruses now